Cardiohepatic interactions in heart failure: An overview and clinical implications

Journal of the American College of Cardiology

Volumn 61, Issue 24, 2013, Pages 2397-2405

  Samsky, Marc D ^a   Patel, Chetan B ^a   Dewald, Tracy A ^a   Smith, Alastair D ^a   Felker, G Michael ^a   Rogers, Joseph G ^a   Hernandez, Adrian F ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

drug metabolism; heart failure; liver injury secondary to heart failure; prognostic markers

Indexed keywords

ACETYLSALICYLIC ACID; AMIODARONE; ANTIARRHYTHMIC AGENT; ANTIBIOTIC AGENT; ANTICOAGULANT AGENT; APIXABAN; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CAPTOPRIL; CLOPIDOGREL; DABIGATRAN; DILTIAZEM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDRALAZINE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; IRBESARTAN; LISINOPRIL; LOSARTAN; PROCAINAMIDE; QUINIDINE; RIVAROXABAN; VERAPAMIL; WARFARIN;

ACUTE DISEASE; AUTOIMMUNE HEPATITIS; BIOCHEMISTRY; CARDIOHEPATIC INTERACTION; CHOLESTASIS; CHRONIC DISEASE; CLINICAL FEATURE; DRUG CLEARANCE; DRUG METABOLISM; GRANULOMATOUS HEPATITIS; HEART FAILURE; HEART TRANSPLANTATION; HISTOPATHOLOGY; HUMAN; LABORATORY TEST; LIVER CONGESTION; LIVER FUNCTION TEST; LIVER INJURY; LIVER TRANSPLANTATION; NONALCOHOLIC FATTY LIVER; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROGNOSIS; REVIEW; TISSUE INTERACTION; TOXIC HEPATITIS;

ALBUMINS; BILIRUBIN; CARDIOLOGY; GAMMA-GLUTAMYLTRANSFERASE; HEART FAILURE; HUMANS; LIVER; LIVER DISEASES; LIVER FUNCTION TESTS; PROGNOSIS; TREATMENT OUTCOME;

EID: 84878924411     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2013.03.042     Document Type: Review

References (63)

1. S.A. Hunt, W.T. Abraham, and M.H. Chin ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult - summary article. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure) J Am Coll Cardiol 46 2005 1116 1143
2. G.L. Smith, J.H. Lichtman, and M.B. Bracken Renal impairment and outcomes in heart failure: systematic review and meta-analysis J Am Coll Cardiol 47 2006 1987 1996
3. E.W. Boland, and F.A. Willius Changes in the liver produced by chronic passive congestion: with special reference to the problem of cardiac cirrhosis Arch Intern Med 62 1938 723 739
4. S. Sherlock The liver in heart failure; relation of anatomical, functional, and circulatory changes Br Heart J 13 1951 273 293
5. J. Henrion Hypoxic hepatitis Liver Int 32 2012 1039 1052
6. J. Henrion, M. Schapira, R. Luwaert, L. Colin, A. Delannoy, and F.R. Heller Hypoxic hepatitis: clinical and hemodynamic study in 142 consecutive cases Medicine (Baltimore) 82 2003 392 406
7. R.K. Seeto, B. Fenn, and D.C. Rockey Ischemic hepatitis: clinical presentation and pathogenesis Am J Med 109 2000 109 113
8. J. Henrion, O. Descamps, R. Luwaert, M. Schapira, A. Parfonry, and F. Heller Hypoxic hepatitis in patients with cardiac failure: incidence in a coronary care unit and measurement of hepatic blood flow J Hepatol 21 1994 696 703
9. V. Fuhrmann, N. Kneidinger, and H. Herkner Hypoxic hepatitis: underlying conditions and risk factors for mortality in critically ill patients Intensive Care Med 35 2009 1397 1405
10. J.M. Raurich, J.A. Llompart-Pou, and M. Ferreruela Hypoxic hepatitis in critically ill patients: incidence, etiology and risk factors for mortality J Anesth 25 2011 50 56
11. J.E. Naschitz, G. Slobodin, R.J. Lewis, E. Zuckerman, and D. Yeshurun Heart diseases affecting the liver and liver diseases affecting the heart Am Heart J 140 2000 111 120
12. J.E. Naschitz, D. Yeshurun, and J. Shahar Cardiogenic hepatorenal syndrome Angiology 41 1990 893 900
13. P.E. Hickman, and J.M. Potter Mortality associated with ischaemic hepatitis Aust N Z J Med 20 1990 32 34
14. C.C. Giallourakis, P.M. Rosenberg, and L.S. Friedman The liver in heart failure Clin Liver Dis 6 2002 947 967
15. G. Kalambokis, P. Manousou, and S. Vibhakorn Transjugular liver biopsy - indications, adequacy, quality of specimens, and complications. A systematic review J Hepatol 47 2007 284 294
16. W.M. Cassidy, and T.B. Reynolds Serum lactic dehydrogenase in the differential diagnosis of acute hepatocellular injury J Clin Gastroenterol 19 1994 118 121
17. A. Mebazaa, M.S. Nieminen, and M. Packer Levosimendan vs dobutamine for patients with acute decompensated heart failure: the SURVIVE randomized trial JAMA 297 2007 1883 1891
18. M. Nikolaou, J. Parissis, and M.B. Yilmaz Liver function abnormalities, clinical profile, and outcome in acute decompensated heart failure Eur Heart J 34 2013 742 749
19. T.B. Horwich, K. Kalanter-Zadeh, R.W. MacLellan, and G.C. Fonarow Albumin levels predict survival in patients with systolic heart failure Am Heart J 155 2008 883 889
20. S. Uthamalingam, J. Kandala, and M. Daley Serum albumin and mortality in acutely decompensated heart failure Am Heart J 160 2010 1149 1155
21. Y. Kinugasa, M. Kato, and S. Sugihara A simple risk score to predict in-hospital death of elderly patients with acute decompensated heart failure - hypoalbuminemia as an additional prognostic factor Circ J 73 2009 2276 2281
22. T.S. Kato, P.C. Schulze, and J. Yang Pre-operative and post-operative risk factors associated with neurologic complications in patients with advanced heart failure supported by a left ventricular assist device J Heart Lung Transplant 31 2012 1 8
23. G. Poelzl, M. Ess, C. Mussner-Seeber, O. Pachinger, M. Frick, and H. Ulmer Liver dysfunction in chronic heart failure: prevalence, characteristics and prognostic significance Eur J Clin Invest 42 2012 153 163
24. G. Poelzl, C. Eberl, and H. Achrainer Prevalence and prognostic significance of elevated gamma-glutamyltransferase in chronic heart failure Circ Heart Fail 2 2009 294 302
25. E. Ruttmann, L.J. Brant, H. Concin, G. Diem, K. Rapp, and H. Ulmer Gamma-glutamyltransferase as a risk factor for cardiovascular disease mortality: an epidemiological investigation in a cohort of 163,944 Austrian adults Circulation 112 2005 2130 2137
26. B. Szyguła-Jurkiewicz, R. Wojnicz, and A. Lekstron [Effect of elevated bilirubin levels on the long-term outcome in patients with chronic heart failure due to hypertension] Pol Arch Med Wewn 117 2007 227 233
27. L.A. Allen, G.M. Felker, and S. Pocock Liver function abnormalities and outcome in patients with chronic heart failure: data from the Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity (CHARM) program Eur J Heart Fail 11 2009 170 177
28. J.C. Matthews, T.M. Koelling, F.D. Pagani, and K.D. Aaronson The right ventricular failure risk score: a pre-operative tool for assessing the risk of right ventricular failure in left ventricular assist device candidates J Am Coll Cardiol 51 2008 2163 2172
29. A.S. Fauci, E. Braunwald, S.L. Hauser, D.L. Longo, J. Jameson, and J. Loscalzo Harrison's Principles of Internal Medicine Vol 2 2008 McGraw-Hill Medical New York, NY
30. S.N. Moussavian, H.P. Dincsoy, S. Goodman, R.A. Helm, and R.C. Bozian Severe hyperbilirubinemia and coma in chronic congestive heart failure Dig Dis Sci 27 1982 175 180
31. S.H. Kubo, B.A. Walter, D.H. John, M. Clark, and R.J. Cody Liver function abnormalities in chronic heart failure. Influence of systemic hemodynamics Arch Intern Med 147 1987 1227 1230
32. G.T. Lau, H.C. Tan, and L. Kritharides Type of liver dysfunction in heart failure and its relation to the severity of tricuspid regurgitation Am J Cardiol 90 2002 1405 1409
33. T.P. Singh, C.S. Almond, M.J. Semigran, G. Piercey, and K. Gauvreau Risk-prediction for early in-hospital mortality following heart transplantation in the United States Circ Heart Fail 5 2012 259 266
34. S. Arques, E. Roux, P. Sbragia, R. Gelisse, B. Pieri, and P. Ambrosi Usefulness of serum albumin concentration for in-hospital risk stratification in frail, elderly patients with acute heart failure. Insights from a prospective, monocenter study Int J Cardiol 125 2008 265 267
35. E. Pasini, C. Opasich, O. Pastoris, and R. Aquilani Inadequate nutritional intake for daily life activity of clinically stable patients with chronic heart failure Am J Cardiol 93 2004 41A 43A
36. R. Aquilani, C. Opasich, and M. Verri Is nutritional intake adequate in chronic heart failure patients? J Am Coll Cardiol 42 2003 1218 1223
37. A.S. Androne, S.D. Katz, and L. Lund Hemodilution is common in patients with advanced heart failure Circulation 107 2003 226 229
38. M.P. Fuhrman, P. Charney, and C.M. Mueller Hepatic proteins and nutrition assessment J Am Diet Assoc 104 2004 1258 1264
39. B.R. Don, and G. Kaysen Poor nutritional status and inflammation: serum albumin: relationship to inflammation and nutrition Semin Dial 17 2004 432 437
40. A. Chokshi, F.H. Cheema, and K.J. Schaefle Hepatic dysfunction and survival after orthotopic heart transplantation: application of the MELD scoring system for outcome prediction J Heart Lung Transplant 31 2012 591 600
41. K. Lietz, J.W. Long, and A.G. Kfoury Outcomes of left ventricular assist device implantation as destination therapy in the post-REMATCH era: implications for patient selection Circulation 116 2007 497 505
42. M.A. Romano, J. Cowger, K.D. Aaronson, and F.D. Pagani Diagnosis and management of right-sided heart failure in subjects supported with left ventricular assist devices Curr Treat Options Cardiovasc Med 12 2010 420 430
43. G.W. Hepner, E.S. Vesell, and K.R. Tantum Reduced drug elimination in congestive heart failure. Studies using aminopyrine as a model drug Am J Med 65 1978 371 376
44. O. Tokola, O. Pelkonen, N.T. Karki, and P. Luoma Hepatic drug-oxidizing enzyme systems and urinary D-glucaric acid excretion in patients with congestive heart failure Br J Clin Pharmacol 2 1975 429 436
45. S.I. Sokol, A. Cheng, W.H. Frishman, and C.S. Kaza Cardiovascular drug therapy in patients with hepatic diseases and patients with congestive heart failure J Clin Pharmacol 40 2000 11 30
46. V. Rodighiero Effects of liver disease on pharmacokinetics. An update Clin Pharmacokinet 37 1999 399 431
47. M. Rowland, and T.N. Tozer Clinical Pharmacokinetics. Concepts and Applications 3rd edition. 1995 Lippincott Williams & Wilkins Media, PA
48. D.J. Morgan, and A.J. McLean Clinical pharmacokinetic and pharmacodynamics considerations in patients with liver disease. An update Clin Pharmacokinet 29 1995 370 391
49. N.L. Benowitz, and W. Meister Pharmacokinetics in patients with cardiac failure Clin Pharmacokinet 1 1976 389 405
50. C. Lambert, J.R. Halpert, J. Rouleau, L. Jutras, V. Leroyer, and P. du Souich Effect of congestive heart failure on the intrinsic metabolic capacity of the liver in the dog Drug Metab Dispos 19 1991 985 989
51. R.K. Verbeeck Pharmacokinetics and dosage adjustment in patients with hepatic dysfunction Eur J Clin Pharmacol 64 2008 1147 1161
52. Guidance for industry: pharmacokinetics in patients with impaired hepatic function: study design, data analysis, and impact on dosing and labeling. Food and Drug Administration Web site, updated May 2003. Available at: http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/ guidances/ucm072123.pdf. Accessed January 11, 2013.
53. R.N. Pugh, I.M. Murray-Lyon, J.L. Dawson, M.C. Pietroni, and R. Williams Transectino of the oesophagus for bleeding oesophageal varices Br J Surg 60 1973 646 649
54. C.G. Child The Liver and Portal Hypertension 1964 WB Saunders Philadelphia, PA
55. T.J. White, C.M. Leevy, A.M. Brusca, and A.M. Gnassi The liver in congestive heart failure Am Heart J 49 1955 250 257
56. C.J. Bjerkelund, and E. Gleditsch Hypoprothrombinemia; occurrence and prognostic significance in congestive heart failure Acta Med Scand 145 1953 181 188
57. S.J. Connolly, M.D. Ezekowitz, and S. Yusuf Dabigatran versus warfarin in patients with atrial fibrillation N Engl J Med 361 2009 1139 1151
58. M.R. Patel, K.W. Mahaffey, and J. Garg Rivaroxaban versus warfarin in nonvalvular atrial fibrillation N Engl J Med 365 2011 883 891
59. C.B. Granger, J.H. Alexander, and J.J. McMurray Apixaban versus warfarin in patients with atrial fibrillation N Engl J Med 365 2011 981 992
60. J.N. Dungu, L.J. Anderson, C.J. Whelan, and P.N. Hawkins Cardiac transthyretin amyloidosis Heart 98 2012 1546 1554
61. B. Kisloff, and G. Schaffer Fulminant hepatic failure secondary to congestive heart failure Dig Dis Sci 21 1976 895 900
62. W. Dichtl, W. Vogel, and K.M. Dunst Cardiac hepatopathy before and after heart transplantation Transpl Int 18 2005 697 702
63. R.M. Cannon, M.G. Hughes, C.M. Jones, M. Eng, and M.R. Marvin A review of the United States experience with combined heart-liver transplantation Transpl Int 25 2012 1223 1228